BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19823766)

  • 1. Inhibition of cholesterol recycling impairs cellular PrP(Sc) propagation.
    Gilch S; Bach C; Lutzny G; Vorberg I; Schätzl HM
    Cell Mol Life Sci; 2009 Dec; 66(24):3979-91. PubMed ID: 19823766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the anti-prion mechanism of four different anti-prion compounds, anti-PrP monoclonal antibody 44B1, pentosan polysulfate, chlorpromazine, and U18666A, in prion-infected mouse neuroblastoma cells.
    Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
    PLoS One; 2014; 9(9):e106516. PubMed ID: 25181483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of intracellular dynamics of inoculated PrP-res and newly generated PrP(Sc) during early stage prion infection in Neuro2a cells.
    Yamasaki T; Baron GS; Suzuki A; Hasebe R; Horiuchi M
    Virology; 2014 Feb; 450-451():324-35. PubMed ID: 24503096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion infection impairs cholesterol metabolism in neuronal cells.
    Cui HL; Guo B; Scicluna B; Coleman BM; Lawson VA; Ellett L; Meikle PJ; Bukrinsky M; Mukhamedova N; Sviridov D; Hill AF
    J Biol Chem; 2014 Jan; 289(2):789-802. PubMed ID: 24280226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an intracellular site of prion conversion.
    Marijanovic Z; Caputo A; Campana V; Zurzolo C
    PLoS Pathog; 2009 May; 5(5):e1000426. PubMed ID: 19424437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for eliminating PrP(c) as substrate for prion conversion and for enhancing PrP(Sc) degradation.
    Gilch S; Nunziante M; Ertmer A; Schätzl HM
    Vet Microbiol; 2007 Aug; 123(4):377-86. PubMed ID: 17493775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative fates of newly formed PrPSc upon prion conversion on the plasma membrane.
    Goold R; McKinnon C; Rabbanian S; Collinge J; Schiavo G; Tabrizi SJ
    J Cell Sci; 2013 Aug; 126(Pt 16):3552-62. PubMed ID: 23813960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.
    Taylor DR; Whitehouse IJ; Hooper NM
    PLoS Pathog; 2009 Nov; 5(11):e1000666. PubMed ID: 19936054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrograde Transport by Clathrin-Coated Vesicles is Involved in Intracellular Transport of PrP
    Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
    Sci Rep; 2018 Aug; 8(1):12241. PubMed ID: 30115966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion infection impairs lysosomal degradation capacity by interfering with rab7 membrane attachment in neuronal cells.
    Shim SY; Karri S; Law S; Schatzl HM; Gilch S
    Sci Rep; 2016 Feb; 6():21658. PubMed ID: 26865414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-prion Protein Antibody 6D11 Restores Cellular Proteostasis of Prion Protein Through Disrupting Recycling Propagation of PrP
    Pankiewicz JE; Sanchez S; Kirshenbaum K; Kascsak RB; Kascsak RJ; Sadowski MJ
    Mol Neurobiol; 2019 Mar; 56(3):2073-2091. PubMed ID: 29987703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of rafts in late endocytic membranes is controlled by NPC1-dependent recycling of cholesterol to the plasma membrane.
    Lusa S; Blom TS; Eskelinen EL; Kuismanen E; Månsson JE; Simons K; Ikonen E
    J Cell Sci; 2001 May; 114(Pt 10):1893-900. PubMed ID: 11329376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus-induced alterations of membrane lipids affect the incorporation of PrP Sc into cells.
    Avrahami D; Dayan-Amouyal Y; Tal S; Mincberg M; Davis C; Abramsky O; Gabizon R
    J Neurosci Res; 2008 Sep; 86(12):2753-62. PubMed ID: 18478553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylphosphatidylinositol anchor analogues sequester cholesterol and reduce prion formation.
    Bate C; Tayebi M; Williams A
    J Biol Chem; 2010 Jul; 285(29):22017-26. PubMed ID: 20427265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc).
    Turnbaugh JA; Unterberger U; Saá P; Massignan T; Fluharty BR; Bowman FP; Miller MB; Supattapone S; Biasini E; Harris DA
    J Neurosci; 2012 Jun; 32(26):8817-30. PubMed ID: 22745483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of small GTPase Rab7 activation in prion infection negatively affects a feedback loop regulating neuronal cholesterol metabolism.
    Cherry P; Lu L; Shim SY; Ebacher V; Tahir W; Schatzl HM; Hannaoui S; Gilch S
    J Biol Chem; 2023 Feb; 299(2):102883. PubMed ID: 36623732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoacylated cellular prion protein modifies cell membranes, inhibits cell signaling, and reduces prion formation.
    Bate C; Williams A
    J Biol Chem; 2011 Mar; 286(11):8752-8. PubMed ID: 21212283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
    Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
    Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts.
    Laffont-Proust I; Hässig R; Haïk S; Simon S; Grassi J; Fonta C; Faucheux BA; Moya KL
    Biol Chem; 2006 Mar; 387(3):297-300. PubMed ID: 16542151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: implications for prion replication and disease pathogenesis.
    Basu S; Mohan ML; Luo X; Kundu B; Kong Q; Singh N
    Mol Biol Cell; 2007 Sep; 18(9):3302-12. PubMed ID: 17567949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.